Human NKG2D/CD314 Alexa Fluor® 647-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # FAB1392R
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
Alexa Fluor 647 (Excitation = 650 nm, Emission = 668 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 1046002
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human NKG2D/CD314
Phe78-Val216
Accession # P26718
Phe78-Val216
Accession # P26718
Specificity
Detects human NKG2D/CD314 in direct ELISA.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for Human NKG2D/CD314 Alexa Fluor® 647-conjugated Antibody
Application
Recommended Usage
Flow Cytometry
Titration recommended for optimal concentration with starting range of 0.1-1 µg/1 million cells. Sample used for this experiment was NK cells (PBMC treated with 27 ng/ml Recombinant Human IL-2 Protein (Catalog # 202-IL), 10 ng/ml Recombinant Human IL-12 Protein (Catalog # 219-IL), 10 ng/ml Recombinant Human IL-18/IL-1F4 Protein (Catalog # 9124-IL) and 10 ng/ml Recombinant Human IL-21 Protein (Catalog # 8879-IL) for 15 days).
Formulation, Preparation, and Storage
Purification
Protein A or G purified from cell culture supernatant
Formulation
Supplied 0.2
mg/mL in a saline solution containing BSA and Sodium Azide.
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Protect from light. Do not freeze.
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: NKG2D/CD314
NKG2D is a type II transmembrane glycoprotein having an extracellular lectin-like domain. This domain lacks the recognizable calcium-binding sites found in true C-type lectins and binds protein rather than carbohydrate ligands. Human NKG2D is expressed on CD8+ alpha beta T cells, gamma delta T cells, NK cells and NKT cells. In mouse systems NKG2D also occurs on macrophages. Human ligands for NKG2D include MICA, MICB, and ULBP1, 2, and 3. Expression of NKG2D ligands occurs in epithelial cells, tumor cells and under conditions of stress or infection. NKG2D exists as a disulfide-linked homodimer that delivers an activating signal upon ligand binding. Signaling requires association with an adapter protein. Alternative splicing of the NKG2D mRNA results in isoforms with different cytoplasmic domains that can associate either with DAP12 to deliver a true activating signal or with DAP10 resulting in a costimulatory signal. NKG2D has been implicated in anti-tumor surveillance and the immune response against viral infection.
References
- Li, P. et al. (2001) Nature Immunol. 2:443.
- Steinle, A. et al. (2001) Immunogenetics 53:279.
- Cosman, D. et al. (2001) Immunity 14:123.
- Cerwenka, A. and L. Lanier (2001) Immunol. Rev. 181:158.
- Wu, J. et al. (1999) Science 285:730.
- Diefenbach, A. et al. (2002) Nature Immunol. 3:1142.
- Gilfillan, S. et al. (2002) Nature Immunol. 3:1150.
- Groh, V. et al. (2001) Nature Immunol. 2:255.
- Cerwenka, A. et al. (2001) Proc. Natl. Acad. Sci. USA 98:11521.
- Diefenbach, A. et al. (2001) Nature 413:165.
- NKG2D and its Ligands (2002) www.rndsystems.com.
Long Name
Natural Killer G2D
Alternate Names
CD314, D12S2489E, KLRK1
Gene Symbol
KLRK1
UniProt
Additional NKG2D/CD314 Products
Product Specific Notices for Human NKG2D/CD314 Alexa Fluor® 647-conjugated Antibody
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
For research use only
Loading...
Loading...
Loading...
Loading...
Loading...